2487 (2487) News
Track canonical SquawkNews coverage tagged to 2487, 2487. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Cutia Therapeutics wins marketing approval for Cu-40102 in Macau
Cutia Therapeutics said its Cu-40102 has received marketing approval from the Macao Pharmaceutical Administration Bureau.
REGULATION | Sep 21, 2026, 01:09 AM UTC
M
Cutia Therapeutics says NMPA accepted biologics license application
Cutia Therapeutics (HKEX:2487) said China’s NMPA accepted its biologics license application for CU-20101.
EQUITY | Sep 02, 2026, 11:47 PM UTC